BackEvoke Pharma Overview

Evoke Pharma Long Term Debt

Track Evoke Pharma's long-term debt ($46K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$46381.00

Peer average

Loading

Evoke Pharma Long Term Debt History

Loading

Evoke Pharma vs. peers: Long Term Debt Comparison

Loading

Evoke Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Evoke Pharma (EVOK) FAQ

Evoke Pharma (EVOK) currently reports a long-term debt of $46K as of September 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Evoke Pharma's long-term debt history and peer comparisons.

Evoke Pharma's long-term debt changed from $0 to $46K (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Evoke Pharma reported $46K in long-term debt as of September 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $46K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Evoke Pharma, and consider following EVOK for alerts when major investors trade the stock.

Evoke Pharma is classified in the Healthcare sector. On long-term debt, it currently shows $46K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EVOK with unrelated industries.